Lingyi Kong Selected Research

oren gedoku to

1/2019	1H NMR-Based Metabolomics Reveals Refined-Huang-Lian-Jie-Du-Decoction (BBG) as a Potential Ischemic Stroke Treatment Drug With Efficacy and a Favorable Therapeutic Window.
10/2017	Comparative study of single/combination use of Huang-Lian-Jie-Du decoction and berberine on their protection on sepsis induced acute liver injury by NMR metabolic profiling.
7/2017	Deciphering the mechanism of Huang-Lian-Jie-Du-Decoction on the treatment of sepsis by formula decomposition and metabolomics: Enhancement of cholinergic pathways and inhibition of HMGB-1/TLR4/NF-κB signaling.
1/2017	Treatment Effects of Ischemic Stroke by Berberine, Baicalin, and Jasminoidin from Huang-Lian-Jie-Du-Decoction (HLJDD) Explored by an Integrated Metabolomics Approach.
1/2017	Optimization of Huang-Lian-Jie-Du-Decoction for Ischemic Stroke Treatment and Mechanistic Study by Metabolomic Profiling and Network Analysis.
12/2016	The components of Huang-Lian-Jie-Du-Decoction act synergistically to exert protective effects in a rat ischemic stroke model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lingyi Kong Research Topics

Disease

42	Neoplasms (Cancer) 08/2022 - 01/2009
10	Inflammation (Inflammations) 07/2022 - 05/2012
8	Breast Neoplasms (Breast Cancer) 10/2021 - 12/2015
6	Colitis 01/2021 - 12/2014
5	Carcinogenesis 01/2022 - 06/2016
5	Ischemic Stroke 01/2022 - 12/2016
5	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 02/2017
5	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 06/2016
5	Sepsis (Septicemia) 11/2020 - 07/2016
4	Osteosarcoma (Osteogenic Sarcoma) 12/2021 - 01/2015
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 11/2020
4	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2017
3	Non-alcoholic Fatty Liver Disease 07/2022 - 01/2021
3	Myeloid Leukemia (Leukemia, Myelocytic) 05/2022 - 01/2017
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2015
3	Stroke (Strokes) 01/2022 - 01/2017
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 12/2016
3	Triple Negative Breast Neoplasms 05/2021 - 10/2018
3	Experimental Arthritis 05/2015 - 01/2015
2	Neuroinflammatory Diseases 01/2022 - 02/2017
2	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 10/2020
2	Glioma (Gliomas) 01/2021 - 01/2017
2	Fibrosis (Cirrhosis) 01/2021 - 11/2020
2	Colonic Neoplasms (Colon Cancer) 10/2020 - 06/2016
2	Type 2 Diabetes Mellitus (MODY) 07/2018 - 08/2014
2	Memory Disorders (Memory Loss) 02/2017 - 03/2013
2	Infarction (Infarctions) 01/2017 - 12/2016
2	Neurologic Manifestations (Neurological Manifestations) 01/2017 - 12/2016
2	Leukemia 01/2017 - 06/2013
2	Parkinson Disease (Parkinson's Disease) 11/2016 - 11/2014
2	Body Weight (Weight, Body) 04/2016 - 12/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2016 - 09/2015
2	Rheumatoid Arthritis 05/2015 - 03/2015
2	Arthritis (Polyarthritis) 05/2015 - 03/2015
1	Tuberous Sclerosis (Bourneville's Disease) 07/2022

Drug/Important Bio-Agent (IBA)

20	Pharmaceutical PreparationsIBA 10/2021 - 08/2014
10	Proteins (Proteins, Gene)FDA Link 07/2022 - 05/2012
6	EnzymesIBA 01/2022 - 01/2019
6	oren gedoku toIBA 01/2019 - 12/2016
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2015
5	AntioxidantsIBA 10/2021 - 12/2016
5	Biological ProductsIBA 10/2020 - 12/2017
5	Dextran SulfateIBA 01/2018 - 12/2014
4	Liposomes (Liposome)IBA 02/2022 - 12/2015
4	Therapeutic UsesIBA 01/2021 - 01/2015
3	LipidsIBA 07/2022 - 12/2015
3	Biomarkers (Surrogate Marker)IBA 07/2022 - 08/2019
3	wogoninIBA 05/2022 - 01/2017
3	Glutathione (Reduced Glutathione)IBA 01/2022 - 05/2013
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2018
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2021 - 11/2016
3	Lysine (L-Lysine)FDA Link 01/2021 - 01/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2019 - 01/2015
3	Amino Acids FDA Link 01/2019 - 07/2016
3	BerberineIBA 10/2017 - 12/2016
3	LipopolysaccharidesIBA 02/2017 - 07/2016
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 12/2009
3	baicalinIBA 01/2017 - 07/2016
3	SaponinsIBA 03/2015 - 10/2005
2	PhytochemicalsIBA 07/2022 - 01/2021
2	CytokinesIBA 02/2022 - 03/2015
2	InflammasomesIBA 01/2022 - 01/2021
2	Histone Deacetylase InhibitorsIBA 01/2022 - 10/2021
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 10/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2012
2	Phosphotransferases (Kinase)IBA 12/2021 - 01/2017
2	tubocapsenolide AIBA 12/2021 - 01/2021
2	withangulatin AIBA 10/2021 - 10/2020
2	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 07/2018
2	cryptotanshinoneIBA 05/2021 - 10/2018
2	ProdrugsIBA 01/2021 - 12/2019
2	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2017
2	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 12/2015
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2020
2	graphene oxideIBA 11/2020 - 01/2018
2	Endoplasmic Reticulum Chaperone BiPIBA 01/2019 - 12/2017
2	Neuroprotective AgentsIBA 01/2019 - 11/2016
2	Cholinergic Agents (Cholinergics)IBA 07/2017 - 03/2013
2	Messenger RNA (mRNA)IBA 01/2017 - 05/2012
2	geniposideIBA 01/2017 - 12/2016
2	FlavonoidsIBA 09/2016 - 09/2015
2	Interleukin-10 (Interleukin 10)IBA 05/2015 - 03/2015
2	praeruptorin AIBA 05/2012 - 07/2010
1	GSK-2816126IBA 08/2022
1	tazemetostatIBA 08/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 07/2022
1	Tripartite Motif ProteinsIBA 07/2022
1	trans-sodium crocetinate (crocetin)IBA 07/2022
1	DEAD-box RNA HelicasesIBA 07/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 07/2022
1	Leucine (L-Leucine)FDA Link 07/2022
1	MicroRNAs (MicroRNA)IBA 07/2022
1	Podophyllotoxin (Condylox)FDA LinkGeneric 02/2022

Therapy/Procedure

27	Therapeutics 02/2022 - 12/2015
6	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019 - 07/2010
4	Ligation 01/2021 - 07/2017
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
3	Punctures 11/2020 - 07/2017
3	Oral Administration 03/2015 - 05/2013